Advertisement

Topics

Popular Biotech News, Healthcare News and Pharma News

06:08 EST 20th January 2018 | BioPortfolio

Acticor Biotech Secures €1,5M New Funding from CapDecisif Management

To accelerate the clinical study of ACT-017, for the emergency treatment of stroke Acticor Biotech, a biotechnology company focused on the treatment of acute ischemic stroke, today announced that it has raised €1,5M from CapDecisif Management. Acticor Biotech had already secured €1,4M in the first closing, which brings the total amount invested to ...

Acticor Biotech Has Selected Its Contract Research Organisation to Manage Clinical Study Phase I

The first-in-human study with ACT017 will be conducted at QPS facilities in Groningen, the Netherlands Acticor Biotech, a biotechnology company focused on the treatment of acute ischemic stroke, today announced that it selected its CRO (Contract Research Organization) to manage its clinical study phase I. This Smart News Release features multimedia. Vie...

FDA approves Solco Healthcare’s Cymbalta generic

David SalazarThe product had brand and generic sales of roughly $484.4 million for the 12 months ended June 2017, according to QuintilesIMS data. read more

Quick Search
Advertisement